1. 1249PDConcomitant radiotherapy in melanoma brain metastases using the propensity score matching within the French cohort, MelBase. (23rd October 2018) Authors: Allayous, C; Oriano, B; Dalle, S; Mortier, L; Leccia, M-T; Guillot, B; Jeudy, G; Dutriaux, C; Lacour, J-P; Saiag, P; Brunet-Possenti, F; De Quatrebarbes, J; Stoebner, P-E; Legoupil, D; Beylot-Barry, M; Lesimple, T; Aubin, F; Ballon, A; Porcher, R; Lebbe, C Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Bipolar mucosal primary cutaneous peripheral T cell lymphoma 'not otherwise specified'. (September 2022) Authors: Grotta, G; Ducharme, O; Fricain, JC; Pham-Ledard, A; Vergier, B; Beylot-Barry, M Journal: European journal of cancer Issue: Volume 173(2022)Supplement 1 Page Start: S35 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Cutaneous lymphocyte antigen (CLA) is a potential therapeutic target in cutaneous T cell lymphoma. (September 2022) Authors: Poglio, S; Péru, S; Prochazkova-Carlotti, M; Cherrier, F; Velazquez, J; Richard, E; Idrissi, Y; Cappellen, D; Azzi-Martin, L; Pham-Ledard, A; Beylot-Barry, M; Merlio, JP Journal: European journal of cancer Issue: Volume 173(2022)Supplement 1 Page Start: S5 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. First xenograft and cell line of primary cutaneous diffuse large B-cell lymphoma, leg type. (September 2022) Authors: Prochazkova-Carlotti, M; Gros, A; Richard, E; Cherrier, F; Laharanne, E; Idrissi, Y; Baron, C; Poglio, S; Ducharme, O; Menguy, S; Pham-Ledard, A; Beylot-Barry, M; Merlio, JP; Bresson-Bepoldin, L Journal: European journal of cancer Issue: Volume 173(2022)Supplement 1 Page Start: S16 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. FRI0584 Rheumatic and musculoskeletal disorders related to immune checkpoint inhibitors in cancer patients: a prospective single-institution study. (15th June 2017) Authors: Marie, K; Rouxel, L; Veillon, R; Martin, F; Dutriaux, C; Pham-Ledard, A; Prey, S; Beylot-Barry, M; Gross-Goupil, M; Bannwarth, B; Richez, C; Mehsen-Cetre, N; Schaeverbeke, T Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 710 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Herpes simplex virus type 2 ascending myeloradiculitis: MRI findings and rapid diagnosis by the polymerase chain method. Issue 7 (July 1994) Authors: Ellie, E; Rozenberg, F; Dousset, V; Beylot-Barry, M Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 57:Issue 7(1994) Page Start: 869 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. How to Manage Inflammatory Bowel Disease Patients When They Withdraw Anti-Tumour Necrosis Factor [Anti-TNF] Due to Severe Anti-TNF-Induced Skin Lesions? A Multicentre Cohort Study. (26th February 2022) Authors: Cottron, C; Treton, X; Altwegg, R; Reenaers, C; Amiot, A; Fumery, M; Vuitton, L; Peyrin-Biroulet, L; Bouguen, G; Dewit, O; Nancey, S; Caillo, L; Roblin, X; Beylot-Barry, M; Rivière, P; Laharie, D Journal: Journal of Crohn's and colitis Issue: Volume 16:Number 8(2022) Page Start: 1202 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Immunophenotypic identification and characterization of CTCL tumor cells in blood using standardized flow cytometry: a European multicenter study. (September 2022) Authors: Najidh, S; Van der Sluijs Gelling, AJ; Cozzio, A; Dobos, G; Bagot, M; Beylot-Barry, M; Guenova, E; Nicolay, J; Lima, M; Ortiz-Romero, PL; Papadavid, E; Pujol, R; Quaglino, P; Stadler, R; Wehkamp, U; Whittaker, S; Van Dongen, JJM; Montero, J Flores; Almeida, J; Vermeer, MH Journal: European journal of cancer Issue: Volume 173(2022)Supplement 1 Page Start: S1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Lacutamab in patients with advanced mycosis fungoides according to KIR3DL2 expression: stage 1 results from the TELLOMAK phase 2 trial. (September 2022) Authors: Bagot, M; Muller, M; Kim, YH; Ortiz-Romero, PL; Zinzani, PL; Beylot-Barry, M; Dalle, S; Jacobsen, E; Combalia, A; Huen, A; Mehta-Shah, N; Khodadoust, MS; Viotti, J; Paiva, C; Porcu, P Journal: European journal of cancer Issue: Volume 173(2022)Supplement 1 Page Start: S20 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. P558 Should we introduce early a new biological agent in patients with Inflammatory Bowel Disease after anti-TNF discontinuation due to severe anti-TNF-induced skin lesions? A multicenter cohort study. (21st January 2022) Authors: Cottron, C; Treton, X; Altwegg, R; Reenaers, C; Amiot, A; Fumery, M; Vuitton, L; Peyrin-Biroulet, L; Bouguen, G; Dewit, O; Nancey, S; Caillo, L; Roblin, X; Beylot-Barry, M; Rivière, P; Laharie, D Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i502 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗